The investment round will also provide significant capital to fuel the company’s expansion plans and pave the way for an exit for existing investor, ADV Partners
Chennai-based Dr Agarwal’s Health Care (DAHCL) has closed a fund raise of Rs 1,050 crore from TPG Growth, the middle market and growth equity platform of alternative asset firm Texas Pacific Group and from existing investor Temasek, a global investment company headquartered in Singapore. The investment round will also provide significant capital to fuel the company’s expansion plans and pave the way for an exit for existing investor, ADV Partners. The company also raised Rs 270 crores investment from Temasek in 2019.
Prof. (Dr) Amar Agarwal, Chairman, Dr Agarwal’s Group of Eye Hospitals said, “We have had a great journey with our investor, ADV Partners, over the past 6 years. We are very excited to partner with TPG Growth and Temasek and look forward to the next phase of growth of our company. Backing from such world-renowned marquee investors further strengthens our ideology of providing quality eyecare to the people and bringing advanced technology to far-reaching corners of the country. The new investments will be used to expand our Indian and international footprint and deploy latest technologies for super-specialty eyecare.”
Dr Agarwal’s Eye Hospitals now has a total network presence of 105 hospitals spread across India and Africa. The group’s presence spans across 11 countries and over 12 states in India.